Drug Type ASO |
Synonyms |
Target |
Mechanism ATXN3 inhibitors(ataxin 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Machado-Joseph Disease | Preclinical | CN | 25 Mar 2024 |